“Anti-TNF Treatment In Refractory Sarcoidosis; Therapeutic Impacts Of Adalimumab And Infliximab”. The Review of Diabetic Studies (April 18, 2025): 120–130. Accessed January 9, 2026. https://diabeticstudies.org/index.php/RDS/article/view/656.